The aim of this study is to compare the efficacy of EUS-guided CPN versus radiofrequency ablation in patients with pain related to pancreatic cancer. By performing a randomized controlled trial, the clinical outcomes and cost-effectiveness of this new RFA treatment approach can be evaluated.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥18 year-old
Patients who give informed consent to the study
Suboptimal pain control with regular analgesics
Inoperable cancer of pancreas
You may not be if
Patients who refuse to give consent
Patients aged \<18 years
EUS not possible due to:
Problem related to scope insertion such as trismus, stenosis of the upper GI tract Coagulopathy with INR \>1.5 or platelet count \< 70
